Journal
NATURE CELL BIOLOGY
Volume 23, Issue 2, Pages 127-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41556-020-00626-1
Keywords
-
Categories
Funding
- Wellcome Trust [206341/Z/17/Z, FC001204]
- Cancer Research UK [FC001204]
- UK Medical Research Council [FC001204]
- Francis Crick Institute
- Bloomington Drosophila Stock Center [NIH P40OD018537]
- Wellcome Trust [206341/Z/17/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
Ribosomes are essential molecular machines for protein synthesis, and deficiencies in ribosomal proteins can lead to proteotoxic stress and cell apoptosis. Modulating the integrated stress response and autophagy can affect the severity of ribosomal protein deficiency-induced harm, suggesting potential cytoprotective strategies for ribosomopathies.
Ribosomes are multicomponent molecular machines that synthesize all of the proteins of living cells. Most of the genes that encode the protein components of ribosomes are therefore essential. A reduction in gene dosage is often viable albeit deleterious and is associated with human syndromes, which are collectively known as ribosomopathies(1-3). The cell biological basis of these pathologies has remained unclear. Here, we model human ribosomopathies in Drosophila and find widespread apoptosis and cellular stress in the resulting animals. This is not caused by insufficient protein synthesis, as reasonably expected. Instead, ribosomal protein deficiency elicits proteotoxic stress, which we suggest is caused by the accumulation of misfolded proteins that overwhelm the protein degradation machinery. We find that dampening the integrated stress response(4) or autophagy increases the harm inflicted by ribosomal protein deficiency, suggesting that these activities could be cytoprotective. Inhibition of TOR activity-which decreases ribosomal protein production, slows down protein synthesis and stimulates autophagy(5)-reduces proteotoxic stress in our ribosomopathy model. Interventions that stimulate autophagy, combined with means of boosting protein quality control, could form the basis of a therapeutic strategy for this class of diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available